Unknown

Dataset Information

0

Defects in the acquisition of tumor-killing capability of CD8+ cytotoxic T cells in streptozotocin-induced diabetic mice.


ABSTRACT: Emerging evidences have shown that diabetes mellitus not only raises risk but also heightens mortality rate of cancer. It is not clear, however, whether antitumor CD8+ cytotoxic T lymphocyte (CTL) response is down-modulated in diabetic hosts. We investigated the impact of hyperglycemia on CTLs' acquisition of tumor-killing capability by utilizing streptozotocin-induced diabetic (STZ-diabetic) mice. Murine diabetes was induced by intraperitoneal injection of STZ (200 mg/kg) in C57BL/6 mice, 2C-T cell receptor (TCR) transgenic and P14-TCR transgenic mice. The study found that, despite harboring intact proliferative capacity measured with CFSE labeling and MTT assay, STZ-diabetic CD8+ CTLs displayed impaired effector functions. After stimulation, STZ-diabetic CD8+ CTLs produced less perforin and TNF? assessed by intracellular staining, as well as expressed less CD103 protein. Furthermore, adoptive transfer of STZ-diabetic P14 CD8+ effector cells showed an insufficient recruitment to the B16.gp33 melanoma and inadequate production of perforin, granzyme B and TNF? determined by immunohistochemistry in the tumor milieu. As a result, STZ-diabetic CD8+ effector cells were neither able to eliminate tumor nor to improve survival of tumor-bearing mice. Taken together, our data suggest that CD8+ CTLs are crippled to infiltrate into tumors and thus fail to acquire tumor-killing capability in STZ-diabetic hosts.

SUBMITTER: Chen SC 

PROVIDER: S-EPMC4229103 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3035066 | BioStudies
2018-01-01 | S-EPMC6431239 | BioStudies
2014-01-01 | S-EPMC3964049 | BioStudies
2009-01-01 | S-EPMC4374745 | BioStudies
2013-12-02 | E-GEOD-51393 | ArrayExpress
2020-01-01 | S-EPMC7516083 | BioStudies
1000-01-01 | S-EPMC3468674 | BioStudies
1000-01-01 | S-EPMC3831973 | BioStudies
2015-01-01 | S-EPMC4324967 | BioStudies
2018-01-01 | S-EPMC5908885 | BioStudies